Cognitive impairment (CI) is a core feature of multiple sclerosis (MS) and affects up to 65%
of patients in every phase of the disease, having a deep impact on all aspects of patients' …

Multiple sclerosis (MS) is characterised not only by physical disability but also by gradual
cognitive impairment. A large proportion of patients exhibit signs of cognitive deficit that …

Abstract Purpose of Review Multiple sclerosis (MS) is a demyelinating disease of the central
nervous system that mainly affects young adults and that is one of the leading causes of …

Of the more than two million people worldwide with multiple sclerosis, 40% to 65%
experience cognitive impairment, many of them early in the course of the disease. Cognitive …

In Multiple Sclerosis (MS) prevalence studies of community and clinical samples, indicate
that 45–60% of patients are cognitively impaired. These cognitive dysfunctions have been …

Introduction Cognitive impairment (CI) has a prevalence of 45–70% in people with multiple
sclerosis (MS), producing a negative impact on their quality of life, personal life, and work …

Abstract Background/Aims: Cognitive dysfunction is a major handicap in multiple sclerosis
(MS). Its prevalence varies due to disease heterogeneity and methodological issues. A …

Background: Cognitive impairments are common in individuals with MS and adversely affect
functioning. Early detection of cognitive impairment, therefore, would enable earlier, and …

Background Cognitive impairment is common in multiple sclerosis (MS) and can have an
impact on all aspects of daily life. It is also an early marker of increased MS disease activity …

Cognitive dysfunction is observed in about half of people with multiple sclerosis (MS), and
MS health-care professionals face the challenge of screening, assessing, and treating …